By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sigma-Tau Pharmaceuticals 

800 South Frederick Avenue, Suite 300

Gaithersburg  Maryland  20877  U.S.A.
Phone: 800-447-0169 Fax:




HEMOSYSTEM┬« SA  exclusive worldwide license for L-carnitine patents related to the blood transfusion field

SciClone Pharmaceuticals, Inc.  European Union partner for the development and commercialization of ZADAXIN in Europe.

Company News
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/2/2014 6:45:51 AM
Sigma-Tau Pharmaceuticals Announces First Patient Dosed In Phase 1/2 Clinical Trial Of STP206 For Prevention Of Necrotizing Enterocolitis In Very Low Birth Weight Premature Infants 2/4/2014 9:14:00 AM
Sigma-Tau PharmaSource, Inc. and Aradigm Corporation (ARDM) Sign Manufacturing Agreement for the Clinical and Commercial Supply of Pulmaquin 9/16/2013 10:00:36 AM
Sigma-Tau Pharmaceuticals Receives Innovation Award From the National Organization for Rare Disorders for Its Advancements in Rare Diseases 5/16/2013 9:12:27 AM
Sigma-Tau Pharmaceuticals Launches CYSTARAN™ for the Treatment of Corneal Cystine Crystal Accumulation in Patients With Cystinosis 5/1/2013 11:44:49 AM
Dave Lemus Promoted to CEO of Sigma-Tau Pharmaceuticals 4/29/2013 8:52:57 AM
Sigma-Tau Pharmaceuticals Announces Appointment of New Vice President of Commercial Operations 10/29/2012 7:10:42 AM
Sigma-Tau Pharmaceuticals Announces the U.S. Launch of VSL#3® JUNIOR 10/16/2012 9:40:06 AM
Sigma-Tau Pharmaceuticals Offers New Co-Pay Assistance Program for Adagen® Patients 10/9/2012 9:12:49 AM
Sigma-Tau Pharmaceuticals Receives FDA Approval of CYSTARAN™ 10/4/2012 7:16:29 AM